Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Malonic Acid SCHEMBL17748563 | 1.00 | USP2 (0.50) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Bicarbonate SCHEMBL20888 | 0.90 | USP2 (0.55) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Glycine SCHEMBL2842691 | 0.89 | USP2 (0.50) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Succinic Acid SCHEMBL17748517 | 0.89 | USP2 (0.50) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Succinic Acid SCHEMBL722957 | 0.89 | USP2 (0.50) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Acetic Acid SCHEMBL7572044 | 0.89 | USP2 (0.53) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Acetic Acid SCHEMBL489053 | 0.89 | USP2 (0.53) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Acetic Acid SCHEMBL8370700 | 0.89 | USP2 (0.53) | USP2SLCO1B1PAX8PDE4ALMNA | |
| Acetic Acid SCHEMBL403998 | 0.89 | USP2 (0.53) | USP2SLCO1B1PAX8PDE4ALMNA | |
| SCHEMBL2227363 | 0.88 | LMNA (0.52) | USP2SLCO1B1PAX8PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10813868-B2 | Method of improving hair volume | CONOPCO, INC. (US) | 2020-10-27 | — | — | US | disclosed |
| EP-3218062-B1 | METHOD OF IMPROVING HAIR VOLUME | UNILEVER PLC (GB) | 2019-09-18 | — | — | EP | disclosed |
| US-20170333328-A1 | METHOD OF IMPROVING HAIR VOLUME | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-11-23 | — | — | US | disclosed |
| EP-3218062-A1 | METHOD OF IMPROVING HAIR VOLUME | Unilever PLC (GB) | 2017-09-20 | — | — | EP | disclosed |
| WO-2016074966-A1 | METHOD OF IMPROVING HAIR VOLUME | UNILEVER PLC (GB) | 2016-05-19 | — | — | WO | disclosed |
| US-20060142207-A1 | Compositions and methods for treating cancer | THRESHOLD PHARMACEUTICALS, INC. (US) | 2006-06-29 | — | — | US | disclosed |
| US-7001888-B2 | Compositions and methods for treating cancer | THRESHOLD PHARMACEUTICALS, INC. (US) | 2006-02-21 | — | — | US | disclosed |
| US-20040029815-A1 | Compositions and methods for treating cancer | THRESHOLD PHARMACEUTICALS, INC. | 2004-02-12 | — | — | US | disclosed |
| WO-2003082301-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THRESHOLD PHARMACEUTICALS, INC. (US) | 2003-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170333328-A1 | METHOD OF IMPROVING HAIR VOLUME | NACA, FTH1, FSCN1 | USP2 3163/4885SLCO1B1 851/4885PAX8 1173/4885 |
| US-20040029815-A1 | Compositions and methods for treating cancer | SLC2A2, SLC2A1, SLC2A3 | USP2 2518/4885SLCO1B1 134/4885PAX8 1966/4885 |
| US-10813868-B2 | Method of improving hair volume | NACA, FTH1, FSCN1 | USP2 3163/4885SLCO1B1 851/4885PAX8 1173/4885 |
| US-20060142207-A1 | Compositions and methods for treating cancer | SLC2A2, SLC2A1, SLC2A3 | USP2 2518/4885SLCO1B1 134/4885PAX8 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.